Er-Kim Pharmaceuticals

Market Access

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals about early access programmes.

News

Armed with new phase 3 data, Bayer is preparing to file a PET imaging agent that could accelerate the diagnosis of cardiac amyloidosis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.